CC BY 4.0 · Arq Neuropsiquiatr 2024; 82(S 02): S53-S176
DOI: 10.1055/s-0045-1806974
ID: 549
Area: Neurogenetics
Presentation method: Eletronic Poster

Case report: DIGFAN syndrome

Renata Yasmin Cardoso Sousa
1   Hospital de Clínicas de Porto Alegre, Porto Alegre RS, Brazil.
,
Aline Da Costa Lourenço
1   Hospital de Clínicas de Porto Alegre, Porto Alegre RS, Brazil.
,
Gabriel De Lellis Neto
1   Hospital de Clínicas de Porto Alegre, Porto Alegre RS, Brazil.
,
Hugo Leonardo Justo Horácio
1   Hospital de Clínicas de Porto Alegre, Porto Alegre RS, Brazil.
,
Olívia Sorato Bezerra
1   Hospital de Clínicas de Porto Alegre, Porto Alegre RS, Brazil.
,
Danielle Dutra Araújo
1   Hospital de Clínicas de Porto Alegre, Porto Alegre RS, Brazil.
,
Josiane Ranzan
1   Hospital de Clínicas de Porto Alegre, Porto Alegre RS, Brazil.
,
Josemar Marchezan
1   Hospital de Clínicas de Porto Alegre, Porto Alegre RS, Brazil.
,
Michele Michelin Becker
1   Hospital de Clínicas de Porto Alegre, Porto Alegre RS, Brazil.
› Author Affiliations
 

    *Correspondence: renatscsousa@gmail.com.

    Abstract

    Case Presentation: A 6-year-old male patient with regression of motor development from 1 year of age, microcephaly, peripheral neuropathy, seizures and severe malnutrition at the time of evaluation. Pre and perinatal and past pathological history without intercurrences. Brain MRI showed significant diffuse volumetric reduction of the cerebellum and minimal dysgenetic changes in the corpus callosum and electroneuromyography with chronic findings of lower motor neuron dysfunction. Panel for lysosomal and neuromuscular diseases without alterations. Exome sequencing was performed, which showed heterozygous de novo pathogenic alterations in the MORC2 gene.

    Discussion: The DIGFAN syndrome (Developmental delay, impaired growth, dysmorphic facies and axonal neuropathy) is characterized by delay or regression of neuropsychomotor development, hypotonia, growth deficit, usually associated with short stature, microcephaly, subtly dysmorphic facial features and neuroimaging changes such as cerebral or cerebellar atrophy, hypomyelination, and lesions in the basal ganglia or brainstem may also occur. Some pathogenic de novo variants in the MORC2 gene are associated with the phenotypic expression of this condition.

    Final Comments: In addition to DIGFAN syndrome, pathogenic alterations in MORC2 are associated with a wide phenotypic variability that encompasses diseases such as Marie-Charcot-Tooth and Spinal muscular atrophy in adults, making the identification of this syndrome a diagnostic challenge. Despite being a rare condition, the analysis of this gene should be considered in genetic panels, such as neurodevelopmental disorders and neuromuscular diseases, for its recognition and early intervention.


    #

    Publication History

    Article published online:
    12 May 2025

    © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

    Thieme Revinter Publicações Ltda.
    Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil